1. Home
  2. CVGI vs TARA Comparison

CVGI vs TARA Comparison

Compare CVGI & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Commercial Vehicle Group Inc.

CVGI

Commercial Vehicle Group Inc.

N/A

Current Price

$2.87

Market Cap

147.9M

ML Signal

N/A

Logo Protara Therapeutics Inc.

TARA

Protara Therapeutics Inc.

N/A

Current Price

$2.73

Market Cap

159.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CVGI
TARA
Founded
2000
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
147.9M
159.6M
IPO Year
2004
2014

Fundamental Metrics

Financial Performance
Metric
CVGI
TARA
Price
$2.87
$2.73
Analyst Decision
Buy
Strong Buy
Analyst Count
2
8
Target Price
$7.50
★ $25.71
AVG Volume (30 Days)
234.6K
★ 1.3M
Earning Date
11-09-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 316.18
38.25
EPS
★ 0.04
N/A
Revenue
★ $755,231,000.00
$2,948,000.00
Revenue This Year
$12.92
N/A
Revenue Next Year
$5.48
N/A
P/E Ratio
$72.00
★ N/A
Revenue Growth
★ 14.06
N/A
52 Week Low
$1.29
$2.51
52 Week High
$5.88
$7.82

Technical Indicators

Market Signals
Indicator
CVGI
TARA
Relative Strength Index (RSI) 35.75 27.38
Support Level $1.45 N/A
Resistance Level $3.31 $4.13
Average True Range (ATR) 0.11 0.22
MACD 0.01 -0.06
Stochastic Oscillator 29.75 15.69

Price Performance

Historical Comparison
CVGI
TARA

About CVGI Commercial Vehicle Group Inc.

Commercial Vehicle Group Inc and its subsidiaries are a globalised provider of systems, assemblies, and components to international commercial vehicle markets and electric vehicle markets. It delivers real solutions to complex design, engineering, and manufacturing problems while creating positive change for customers, industries, and communities it serves. The company has its manufacturing operations in the United States, Mexico, China, the United Kingdom, the Czech Republic, Ukraine, Morocco, Thailand, India, and Australia. Organisations' products are mainly sold in North America, Europe, and the Asia-Pacific region. It has three segments: Global Seating Segment, Global Electrical systmem, and Trim Systems and Components Segment, with the majority of revenue from Global Seating Segment.

About TARA Protara Therapeutics Inc.

Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.

Share on Social Networks: